Latest News
Our methodology research at ICTMC 2024
MRC CTU at UCL methodology researchers will have a large turnout at the 7th International Clinical Trials Methodology Conference in Edinburgh, UK.
New podcast episode: Preventing multidrug-resistant tuberculosis
In this episode of the Trial Talk podcast, we find out more about the TB-CHAMP and VQUIN trials, and how the teams came together to combine their data and strengthen their evidence.
No clear evidence that adding diabetes drug to standard prostate cancer treatment reduces risk of death, but side effects of hormone therapy lessened
New results from the STAMPEDE trial metformin comparison were presented at the 2024 ESMO Congress.
Hormone patches are as effective as hormone injections for people with non-metastatic prostate cancer
New results from the PATCH and STAMPEDE trials could increase the treatment options available for people with prostate cancer who are starting long-term hormone therapy.
'25 at 25': Transforming prostate cancer treatment through the STAMPEDE clinical trial
As part of our 25th anniversary celebrations, we look at the many achievements of the STAMPEDE clinical trial, which has tested 10 different treatments and changed the standard-of-care for prostate cancer four times in less than 20 years.